Free Trial
TSE:IMV

IMV (IMV) Stock Price, News & Analysis

IMV logo
C$1.12
-0.02 (-1.75%)
(As of 04/28/2023)

About IMV Stock (TSE:IMV)

Key Stats

Today's Range
C$1.07
C$1.13
50-Day Range
C$1.12
C$1.12
52-Week Range
C$0.62
C$15.90
Volume
15,761 shs
Average Volume
56,822 shs
Market Capitalization
C$13.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Receive IMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

IMV Stock News Headlines

Toyota's Cheapest Truck Goes Racing
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
See More Headlines

IMV Stock Analysis - Frequently Asked Questions

IMV's stock was trading at C$1.12 at the beginning of 2024. Since then, IMV stock has increased by 0.0% and is now trading at C$1.12.
View the best growth stocks for 2024 here
.

Shares of IMV reverse split on the morning of Monday, December 12th 2022. The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Manulife Financial (MFC), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN) and Enbridge (ENB).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Hardware
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
C$-37,990,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$23,000.00
Cash Flow
C$0.70 per share
Book Value
C($0.69) per share

Miscellaneous

Free Float
N/A
Market Cap
C$13.12 million
Optionable
Not Optionable
Beta
1.52
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (TSE:IMV) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners